User profiles for Gideon M. Hirschfield
Gideon HirschfieldUniversity of Toronto Verified email at uhn.ca Cited by 42434 |
[HTML][HTML] C-reactive protein: a critical update
MB Pepys, GM Hirschfield - The Journal of clinical …, 2003 - Am Soc Clin Investig
In the mid 1990s, immunoassays for C-reactive protein (CRP), with greater sensitivity than
those previously in routine use, revealed that increased CRP values, even within the range …
those previously in routine use, revealed that increased CRP values, even within the range …
[HTML][HTML] C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
J Danesh, JG Wheeler, GM Hirschfield… - New England journal …, 2004 - Mass Medical Soc
Background C-reactive protein is an inflammatory marker believed to be of value in the
prediction of coronary events. We report data from a large study of C-reactive protein and other …
prediction of coronary events. We report data from a large study of C-reactive protein and other …
The gut microbiota and host health: a new clinical frontier
Over the last 10–15 years, our understanding of the composition and functions of the human
gut microbiota has increased exponentially. To a large extent, this has been due to new ‘…
gut microbiota has increased exponentially. To a large extent, this has been due to new ‘…
[HTML][HTML] A placebo-controlled trial of obeticholic acid in primary biliary cholangitis
…, V Vargas, C Vincent, GM Hirschfield… - … England Journal of …, 2016 - Mass Medical Soc
Background Primary biliary cholangitis (formerly called primary biliary cirrhosis) can progress
to cirrhosis and death despite ursodiol therapy. Alkaline phosphatase and bilirubin levels …
to cirrhosis and death despite ursodiol therapy. Alkaline phosphatase and bilirubin levels …
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Primary biliary cholangitis (PBC) is a chronic inflammatory autoimmune cholestatic liver
disease, which when untreated will culminate in end-stage biliary cirrhosis. Diagnosis is usually …
disease, which when untreated will culminate in end-stage biliary cirrhosis. Diagnosis is usually …
Targeting C-reactive protein for the treatment of cardiovascular disease
MB Pepys, GM Hirschfield, GA Tennent… - Nature, 2006 - nature.com
Complement-mediated inflammation exacerbates the tissue injury of ischaemic necrosis in
heart attacks and strokes, the most common causes of death in developed countries. Large …
heart attacks and strokes, the most common causes of death in developed countries. Large …
[HTML][HTML] Primary Biliary Cirrhosis Associated with HLA, IL12A, and IL12RB2 Variants
GM Hirschfield, X Liu, C Xu, Y Lu, G Xie… - … England Journal of …, 2009 - Mass Medical Soc
Background Primary biliary cirrhosis is a chronic granulomatous cholangitis, characteristically
associated with antimitochondrial antibodies. Twin and family aggregation data suggest …
associated with antimitochondrial antibodies. Twin and family aggregation data suggest …
[HTML][HTML] Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid
Background & Aims We evaluated the efficacy and safety of obeticholic acid (OCA, α-ethylchenodeoxycholic
acid) in a randomized controlled trial of patients with primary biliary …
acid) in a randomized controlled trial of patients with primary biliary …
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
…, TB Harris, AL Hartikainen, S Heath, GM Hirschfield… - Nature …, 2011 - nature.com
Concentrations of liver enzymes in plasma are widely used as indicators of liver disease.
We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci …
We carried out a genome-wide association study in 61,089 individuals, identifying 42 loci …
Primary sclerosing cholangitis
GM Hirschfield, TH Karlsen, KD Lindor, DH Adams - The Lancet, 2013 - thelancet.com
… Gideon M Hirschfield … Correspondence to: Dr Gideon M Hirschfield, Centre for Liver Research,
National Institute for Health Research Biomedical Research Unit, University of Birmingham…
National Institute for Health Research Biomedical Research Unit, University of Birmingham…